Syntegra
Syntegra is a healthcare artificial-intelligence company focused on generating privacy-preserved synthetic healthcare data. Its proprietary Syntegra Medical Mind uses machine-learning and transformer-based generative models to learn statistical patterns from structured healthcare data—including EHRs, claims, registries, and clinical-trial data—and produce realistic but non-identifiable patient-level datasets. The company positioned its platform for health systems, life-science and digital-health companies, payers, clinical research organizations, and data scientists, with applications including real-world evidence, clinical research, drug development, healthcare innovation, and model development. Publicly reported partnerships and collaborations included the NIH and Bill & Melinda Gates Foundation on COVID-19/N3C data, the Institute for Health Metrics, Nashville Biosciences, TMA Precision Health, Atropos Health, and Datavant. Syntegra was recognized in the 2021 CB Insights Digital Health 150. Public sources conflict on its current status: PitchBook lists it as out of business as of 2025, while the latest clearly documented company announcements found were from 2022; therefore, its present operating status and current market position cannot be independently confirmed. Historically, it was an early specialist in generative AI for synthetic healthcare data, competing in the broader healthcare-data privacy, synthetic-data, and real-world-evidence market.
Company Details
- Website
- syntegra.io
- Headquarters
- San Mateo, California, United States (historical public listing); earlier company announcements described Syntegra as San Francisco-based
- Founded
- 2019
- Funding
- $5.625M publicly announced seed financing; some databases report approximately $8.7M total, but that
Subscriber Intelligence
- • Deal signal alerts for this company
- • Sentiment & risk scoring
- • Competitive framework analysis
- • Regulatory event monitoring